NCT07177456View on ClinicalTrials.gov

Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Radiation-induced Lung Injury
Interventions
BIOLOGICAL

UCB-MNCs

UCB-MNCs were administered via intravenous infusion three times, once per week, with a dose of 3×10⁸ cells per infusion.

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER